Titan Pharmaceuticals Inc. (TTNP) Declined -5.83% or -0.06 To Price $0.97 On Tuesday


Titan Pharmaceuticals Inc. (TTNP) declined -5.83% or -0.06 to $0.97. It is nearly 34515 shares traded, which is 37.26% compare to the average total volume 92632. The market cap of TTNP is $20.57 million. The year to date change is -26.43%. The 52 week price range is from $0.95 to $3.95. Price of TTNP have changed 3.00% during last week. It have changed -14.17% over last month, -33.55% over last 3 months, -35.63% over last 6 months and -72.16% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TTNP is 1.23. It is 26.80% above current price. The 200-day Moving Averages for TTNP is 1.71. It is 76.29% above current price. The 52-week High is 3.95. It is 307.22% from the current price. The 52-week Low is 0.95. It is -2.06% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of TTNP is 6.41 on 2018-02-15. Short % to float is 3.58%. There are some statistics of TTNP. It is has market cap $20.57 million. The share outstanding is 21.20 million. The average volume is 92632. The revenue is 192000. The percent of top 15 Institution holding is 2.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TTNP is -134.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TTNP is -71.53%.


Tags:

Share this post